Halter Ferguson Financial Inc. Candel Therapeutics, Inc. Transaction History
Halter Ferguson Financial Inc.
- $244 Billion
- Q4 2024
A detailed history of Halter Ferguson Financial Inc. transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Halter Ferguson Financial Inc. holds 681,334 shares of CADL stock, worth $5.1 Million. This represents 2.42% of its overall portfolio holdings.
Number of Shares
681,334
Previous 304,539
123.73%
Holding current value
$5.1 Million
Previous $2.11 Billion
180.22%
% of portfolio
2.42%
Previous 1.12%
Shares
2 transactions
Others Institutions Holding CADL
# of Institutions
77Shares Held
15.6MCall Options Held
981KPut Options Held
521K-
Baker Bros. Advisors LP New York, NY2.98MShares$22.3 Million0.29% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.94MShares$14.5 Million9.1% of portfolio
-
Northpond Ventures, LLC1.94MShares$14.5 Million48.35% of portfolio
-
Braidwell LP Stamford, CT1.6MShares$12 Million0.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$10 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $216M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...